Vaginal dryness, painful intimacy, or frequent UTIs after menopause?

Vaginal dryness, discomfort with intimacy, and frequent urinary tract infections are not things you have to “just live with.” At Nervana Medical, we see many peri- and postmenopausal women from Sandy and the greater Salt Lake City area who are frustrated by these symptoms and looking for real, evidence-based relief.

One of the most effective and well-studied options is low-dose vaginal estradiol, a localized estrogen therapy that treats the underlying cause rather than just masking symptoms.

---

Why Vaginal Dryness and UTIs Increase After Menopause

As estrogen levels decline during peri- and postmenopause, the vaginal and urinary tissues become thinner, drier, and more fragile. These changes can lead to:

• Vaginal dryness, burning, or irritation
• Pain with intimacy
• Recurrent urinary tract infections
• Urinary urgency or discomfort

Lower estrogen also disrupts the vaginal microbiome and raises vaginal pH, creating an environment where harmful bacteria are more likely to grow.

---

How Vaginal Estradiol Works

Vaginal estradiol cream delivers a very low dose of estrogen directly to the vaginal tissue. Unlike oral estrogen, it works locally and targets the tissues most affected by estrogen loss.

Clinical studies show that vaginal estradiol:

• Restores thickness and elasticity of the vaginal lining
• Improves lubrication and comfort
• Supports a healthy vaginal microbiome
• Lowers vaginal pH, making it harder for infection-causing bacteria to survive
• Significantly reduces the risk of recurrent UTIs

Large studies demonstrate more than a 50% reduction in UTI frequency in hypoestrogenic women using vaginal estrogen, along with meaningful improvement in dryness and urinary symptoms.

Importantly, oral estrogen does not provide the same protection against UTIs, which is why local therapy is recommended. Our hormone patients are usually on both, topical vaginal estradiol and also oral or transdermal estradiol. There is a place for both of these routes (stay tuned to learn more on oral estradiol benefits).

---

Is Vaginal Estradiol Safe?

For most women, vaginal estradiol is very safe. Systemic absorption is minimal, and serious side effects are rare. Major medical guidelines support its use for vaginal dryness and prevention of recurrent UTIs in peri- and postmenopausal patients.

For women with a history of estrogen-sensitive cancers, non-hormonal vaginal moisturizers are typically tried first. If symptoms persist, low-dose vaginal estradiol may still be considered in coordination with an oncology team, depending on individual risk factors.

---

What to Expect

Many patients notice improvement in comfort, dryness, and urinary symptoms within weeks of starting therapy. Because the treatment works locally, it addresses the root cause of symptoms rather than providing temporary relief.

Different vaginal estrogen formulations are available, and while long-term comparative data is still evolving, all approved vaginal estrogen options are effective for vulvovaginal atrophy and UTI prevention.

*Trick: Use a dab of vaginal estradiol cream to your face cream for additional hydration! Low estrogen can lead to a 30% loss of collagen; hence the “aging face”. 

---

Personalized Care at Nervana Medical in Sandy, Utah

Vaginal dryness and recurrent UTIs are common but they are also treatable. At Nervana Medical, we take the time to review your history, symptoms, and goals so we can recommend the right approach, whether that includes local estradiol, non-hormonal options, or combination care.

If you live in Sandy or the Salt Lake City area or any of our neighboring states we service and want a personalized plan to improve comfort, intimacy, and urinary health, schedule a consultation with our team. We’re here to help you feel comfortable, confident, and well again.

References

1. Updates to Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline. Anger JT, Bixler BR, Holmes RS, et al. The Journal of Urology. 2022;208(3):536-541. doi:10.1097/JU.0000000000002860.
2. American Urogynecologic Society Best-Practice Statement: Recurrent Urinary Tract Infection in Adult Women. Brubaker L, Carberry C, Nardos R, Carter-Brooks C, Lowder JL. Female Pelvic Medicine & Reconstructive Surgery. 2018 Sep/Oct;24(5):321-335. doi:10.1097/SPV.0000000000000550.
3. Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria®. Steinman MA. Journal of the American Geriatrics Society. 2025;73(9):2657-2677. doi:10.1111/jgs.19500.
4. Hormone Therapy for Postmenopausal Women. Pinkerton JV. The New England Journal of Medicine. 2020;382(5):446-455. doi:10.1056/NEJMcp1714787.
5. Vaginal Estrogen for Genitourinary Syndrome of Menopause: A Systematic Review. Rahn DD, Carberry C, Sanses TV, et al. Obstetrics and Gynecology. 2014;124(6):1147-1156. doi:10.1097/AOG.0000000000000526.
6. Estrogen for the Prevention of Recurrent Urinary Tract Infections in Postmenopausal Women: A Meta-Analysis of Randomized Controlled Trials. Chen YY, Su TH, Lau HH. International Urogynecology Journal. 2021;32(1):17-25. doi:10.1007/s00192-020-04397-z.
7. Efficacy of Vaginal Estrogen for Recurrent Urinary Tract Infection Prevention in Hypoestrogenic Women. Tan-Kim J, Shah NM, Do D, Menefee SA. American Journal of Obstetrics and Gynecology. 2023;229(2):143.e1-143.e9. doi:10.1016/j.ajog.2023.05.002.
8. Enhancing Quality of Life: Addressing Vulvovaginal Atrophy and Urinary Tract Symptoms. Hirschberg AL. Climacteric : The Journal of the International Menopause Society. 2025;:1-8. doi:10.1080/13697137.2025.2514029.
9. Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause : A Systematic Review. Danan ER, Sowerby C, Ullman KE, et al. Annals of Internal Medicine. 2024;177(10):1400-1414. doi:10.7326/ANNALS-24-00610.